Related Experiment Video
Updated: May 15, 2026

08:41
Mouse Round Spermatid Injection
Published on: January 26, 2024
Does intracytoplasmic morphologically selected sperm injection improve embryo development? A randomized
A De Vos1, H Van de Velde, G Bocken
1Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium. anick.devos@uzbrussel.be
Human Reproduction (Oxford, England)
|January 8, 2013
Summary
High-magnification sperm selection (IMSI) did not improve oocyte fertilization or embryo development compared to conventional ICSI. Routine IMSI is not recommended for all patients undergoing assisted reproduction.
Area of Science:
- Reproductive Medicine
- Embryology
- Andrology
Background:
- Sperm nuclear vacuoles can impact embryo development and blastocyst formation.
- High-magnification sperm selection (IMSI) has been linked to improved pregnancy and reduced miscarriage rates.
Purpose of the Study:
- To investigate if high-magnification sperm selection influences oocyte fertilization and embryo development.
- To compare intracytoplasmic morphologically selected sperm injection (IMSI) with conventional intracytoplasmic sperm injection (ICSI).
Main Methods:
- A prospective sibling-oocyte study involving 350 ICSI cycles for male infertility.
- Sperm morphology assessed using high magnification (IMSI) on at least 200 spermatozoa per sample.
- Primary endpoints included oocyte fertilization rate and embryo development; clinical outcomes were descriptive.
Main Results:
- Oocyte fertilization rates were similar: 79.1% for IMSI and 77.3% for ICSI.
- Embryo development up to Day 5 was comparable between IMSI and ICSI groups.
- Clinical pregnancy rates were also similar: 34.4% for IMSI-only and 36.7% for ICSI-only embryo transfers.
Conclusions:
- High-magnification sperm selection (IMSI) demonstrated no significant difference in fertilization or embryo development compared to conventional ICSI.
- The prevalence of vacuoles in normal-shaped sperm is low (27.5%).
- Routine IMSI application in unselected assisted reproductive technology patients is not currently advocated.

